141 related articles for article (PubMed ID: 29424052)
1. Persistence of plasmid-mediated expression of transgenes in human mesenchymal stem cells depends primarily on CpG levels of both vector and transgene.
Bruter AV; Kandarakov OF; Belyavsky AV
J Gene Med; 2018 Feb; 20(2-3):e3009. PubMed ID: 29424052
[TBL] [Abstract][Full Text] [Related]
2. [Maintenance of Plasmid Expression in vivo Depends Primarily on the CpG Contents of the Vector and Transgene].
Bruter AV; Kalashnikova MV; Prytyko AP; Belyavsky AV
Mol Biol (Mosk); 2020; 54(3):487-496. PubMed ID: 32492013
[TBL] [Abstract][Full Text] [Related]
3. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
4. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
Reyes-Sandoval A; Ertl HC
Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids.
Ratanamart J; Huggins CG; Kirby JA; Shaw JA
J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049
[TBL] [Abstract][Full Text] [Related]
6. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides.
Hodges BL; Taylor KM; Joseph MF; Bourgeois SA; Scheule RK
Mol Ther; 2004 Aug; 10(2):269-78. PubMed ID: 15294174
[TBL] [Abstract][Full Text] [Related]
7. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.
Chen ZY; Riu E; He CY; Xu H; Kay MA
Mol Ther; 2008 Mar; 16(3):548-56. PubMed ID: 18253155
[TBL] [Abstract][Full Text] [Related]
8. Durable Transgene Expression Driven by CpG-Free and -Containing Promoters in Plasmid DNA with CpG-Free Backbone.
Suzuki T; Goda T; Kamiya H
Biol Pharm Bull; 2018; 41(9):1489-1493. PubMed ID: 30175785
[TBL] [Abstract][Full Text] [Related]
9. Building mosaics of therapeutic plasmid gene vectors.
Tolmachov OE
Curr Gene Ther; 2011 Dec; 11(6):466-78. PubMed ID: 22023476
[TBL] [Abstract][Full Text] [Related]
10. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
11. A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells.
Ren X; Katoh M; Hoshiya H; Kurimasa A; Inoue T; Ayabe F; Shibata K; Toguchida J; Oshimura M
Stem Cells; 2005; 23(10):1608-16. PubMed ID: 16141362
[TBL] [Abstract][Full Text] [Related]
12. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
13. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver.
Suzuki T; Wakao Y; Goda T; Kamiya H
J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985
[TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells.
Ribeiro S; Mairhofer J; Madeira C; Diogo MM; Lobato da Silva C; Monteiro G; Grabherr R; Cabral JM
Cell Reprogram; 2012 Apr; 14(2):130-7. PubMed ID: 22339198
[TBL] [Abstract][Full Text] [Related]
15. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
Riu E; Grimm D; Huang Z; Kay MA
Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
[TBL] [Abstract][Full Text] [Related]
16. Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression.
Krinner S; Heitzer A; Asbach B; Wagner R
Hum Gene Ther; 2015 Dec; 26(12):826-40. PubMed ID: 26414116
[TBL] [Abstract][Full Text] [Related]
17. The β-interferon scaffold attachment region confers high-level transgene expression and avoids extinction by epigenetic modifications of integrated provirus in adipose tissue-derived human mesenchymal stem cells.
Moreno R; Martínez I; Petriz J; Nadal M; Tintoré X; Gonzalez JR; Gratacós E; Aran JM
Tissue Eng Part C Methods; 2011 Mar; 17(3):275-87. PubMed ID: 20846052
[TBL] [Abstract][Full Text] [Related]
18. CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
Pringle IA; Hyde SC; Connolly MM; Lawton AE; Xu B; Nunez-Alonso G; Davies LA; Sumner-Jones SG; Gill DR
Biomaterials; 2012 Oct; 33(28):6833-42. PubMed ID: 22727465
[TBL] [Abstract][Full Text] [Related]
19. Transgene expression from CpG-reduced lentiviral gene delivery vectors in vitro.
Low PT; Lai MI; Ngai SC; Abdullah S
Gene; 2014 Jan; 533(1):451-5. PubMed ID: 24120896
[TBL] [Abstract][Full Text] [Related]
20. Anatomy of plasmid DNAs with anti-silencing elements.
Kanda GN; Miyamoto S; Kobayashi M; Matsuoka I; Harashima H; Kamiya H
Int J Pharm; 2014 Apr; 464(1-2):27-33. PubMed ID: 24472643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
